Animal experiments indicate that repeated exposure to ketamine adversely affects the developing brain. Whether it has the same effect on infants remains unclear. We recruited infants who were scheduled for 1 to 3 outpatient laser surgery treatments of benign facial growths with ketamine anesthesia. Patients were assigned to the Ket1, Ket2, or Ket3 group, according to the number of treatments. The Bayley Scales of Infant Development–Second Edition (BSID-II) was used to assess neurodevelopmental outcomes before the first and after the last therapy. Levels of S-100β were also measured. Bayley Scales of Infant Development–Second Edition scores after the last procedure were lower than those before the first surgery in the Ket3 group (P < .05). S-100β levels after the last procedure were significantly higher than those before the first surgery in all groups (P < .05). Our results suggest that 3 or more exposures to anesthetic ketamine have the potential to adversely affect neurodevelopment in infants.
IkonomidouCBoschFMiksaM. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283:70–74.
2.
HayashiHDikkesPSorianoSG. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth. 2002;12:770–774.
3.
PauleMGLiMAllenRR. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol. 2011;33:220–230.
4.
ShiQGuoLPattersonTA. Gene expression profiling in the developing rat brain exposed to ketamine. Neuroscience. 2010;166:852–863.
5.
ZouXPattersonTADivineRL. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci. 2009;27:727–731.
6.
ZouXPattersonTASadovovaN. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci. 2009;108:149–158.
7.
GuerraGGRobertsonCMAltonGY. Neurodevelopmental outcome following exposure to sedative and analgesic drugs for complex cardiac surgery in infancy. Paediatr Anaesth. 2011;21:932–941.
8.
BhuttaATSchmitzMLSwearingenC. Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trial. Pediatr Crit Care Med. 2012;13:328–337.
9.
HerrmannMEbertADGalazkyIWunderlichMTKunzWSHuthC. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke. 2000;31:645–650.
10.
IkonomidouCBittigauPKochC. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol. 2001;62:401–405.
11.
OlneyJWWozniakDFJevtovic-TodorovicV. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 2002;12:488–498.
12.
StraikoMMYoungCCattanoD. Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology. 2009;110:862–868.
13.
SunL. Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth. 2010;105(suppl 1):i61–i68.
14.
WangCSlikkerWJr. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system. Anesth Analg. 2008;106:1643–1658.
15.
BartelsMAlthoffRRBoomsmaDI. Anesthesia and cognitive performance in children: no evidence for a causal relationship. Twin Res Hum Genet. 2009;12:246–253.
16.
DiMaggioCSunLSKakavouliAByrneMWLiG. A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. J Neurosurg Anesthesiol. 2009;21:286–291.
17.
KalkmanCJPeelenLMoonsKG. Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology. 2009;110:805–812.
18.
SprungJFlickRPKatusicSK. Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia. Mayo Clin Proc. 2012;87:120–129.
19.
WilderRTFlickRPSprungJ. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology. 2009;110:796–804.
20.
DavidsonAJ. Anesthesia and neurotoxicity to the developing brain: the clinical relevance. Paediatr Anaesth. 2011;21:716–721.
21.
FlickRPWilderRTSprungJ. Anesthesia and cognitive performance in children: no evidence for a causal relationship. Are the conclusions justified by the data? Response to Bartels et al., 2009. Twin Res Hum Genet. 2009;12:611–612; discussion 613-614.
22.
LoepkeAWMcGowanFXJrSorianoSG. CON: the toxic effects of anesthetics in the developing brain: the clinical perspective. Anesth Analg. 2008;106:1664–1669.
23.
ShuYZhouZWanY. Nociceptive stimuli enhance anesthetic-induced neuroapoptosis in the rat developing brain. Neurobiol Dis. 2012;45:743–750.
24.
SorianoSGAnandKJ. Anesthetics and brain toxicity. Curr Opin Anaesthesiol. 2005;18:293–297.
25.
LiuJRLiuQLiJ. Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain. Anesthesiology. 2012;117:64–71.
26.
LiuFPauleMGAliSWangC. Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol. 2011;9:256–261.
27.
LiuFPattersonTASadovovaN. Ketamine-induced neuronal damage and altered N-methyl-d-aspartate receptor function in rat primary forebrain culture. Toxicol Sci. 2013;131:548–557.
28.
PengSZhangYWangHRenBZhangJ. Anesthetic ketamine counteracts repetitive mechanical stress-induced learning and memory impairment in developing mice. Mol Biol Rep. 2011;38:4347–4351.
29.
FredrikssonAArcherTAlmHGordhTErikssonP. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res. 2004;153:367–376.
30.
SlikkerWJrPauleMGWrightLKPattersonTAWangC. Systems biology approaches for toxicology. J Appl Toxicol. 2007;27:201–217.
31.
UllahNUllahILeeHY. Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain. J Mol Neurosci. 2012;47:67–75.
